Five Year Outcome of Lentiviral Gene Therapy for Human Beta-Thalassemia, Lessons and Prospects
Excerpt
This article is distributed under the terms of the Creative Commons [...]
Share and Cite
Leboulch, P. Five Year Outcome of Lentiviral Gene Therapy for Human Beta-Thalassemia, Lessons and Prospects. Thalass. Rep. 2013, 3, e43. https://doi.org/10.4081/thal.2013.s1.e43
Leboulch P. Five Year Outcome of Lentiviral Gene Therapy for Human Beta-Thalassemia, Lessons and Prospects. Thalassemia Reports. 2013; 3(s1):e43. https://doi.org/10.4081/thal.2013.s1.e43
Chicago/Turabian StyleLeboulch, Philippe. 2013. "Five Year Outcome of Lentiviral Gene Therapy for Human Beta-Thalassemia, Lessons and Prospects" Thalassemia Reports 3, no. s1: e43. https://doi.org/10.4081/thal.2013.s1.e43
APA StyleLeboulch, P. (2013). Five Year Outcome of Lentiviral Gene Therapy for Human Beta-Thalassemia, Lessons and Prospects. Thalassemia Reports, 3(s1), e43. https://doi.org/10.4081/thal.2013.s1.e43